Entries by aaron

Sanofi India names Himanshu Bakshi as General Manager for Consumer Healthcare Business

Sanofi India Limited (SIL) has announced the appointment of Himanshu Bakshi as General Manager for its Consumer Healthcare (CHC) business, effective 15th January 2024. SIL earlier this year had announced that the Company’s Consumer Healthcare business will be demerged into its wholly owned subsidiary, Sanofi Consumer Healthcare India Limited (SCHIL), subject to necessary approvals and […]

Breaking News: Home Minister Amit Shah Promises to Decriminalize Medical Negligence

New Delhi: In an unprecedented move, Union Home Minister Amit Shah has promised in the Parliament to decriminalise medical negligence by doctors, drawing a big cheer from the entire medical fraternity. Addressing the Lok Sabha, the Home Minister stated, “Currently, if there is a death due to negligence of a doctor, it is also treated as […]

NMC warns medical colleges to ensure 75 percent faculty attendance or lose recognition

Few days after issuing show-cause notices to over 350 medical colleges after finding a deficiency in attendance and failure to meet required faculty requirements (Minimum Standard Requirements 2020), the National Medical Commission (NMC) has now issued a warning for the institutions directing them to strictly follow UG-MSR 2023 and MSMER 2023 otherwise their applications will […]

FDA approves birch triterpenes gel as topical medication for epidermolysis bullosa

The US Food and Drug Administration (FDA) has approved the new birch triterpenes topical gel (Filsuvez) for treating 2 variants of epidermolysis bullosa (EB).Birch triterpenes topical gel is designed for partial thickness wounds in seen in individuals aged 6 months and older with a diagnosis of Junctional Epidermolysis Bullosa (JEB) and with Dystrophic Epidermolysis Bullosa […]

JB Pharma enters Opthalmology space, signs Rs 1,089 crore deal with Novartis for 10 brands

New Delhi: JB Chemicals & Pharmaceuticals Ltd (JB Pharma) has announced that the Company has inked a trade mark licence agreement along with promotion and distribution pact with Novartis for select ophthalmology brands entailing a total sum of Rs 1,089 crore. The acquired brands include Simbrinza, Travatan, Travacom, Azopt, Azarga, Vigamox, Nevanac, Ilevro, Vigadexa, Pataday. […]

AIIMS releases Schedule Of First MBBS Supplementary Professional Exams, details

Delhi: All India Institute of Medical Sciences (AIIMS) has released the schedule of the first MBBS (Supplementary) professional examinations to be held in December 2023 to January 2024. The examinations begin on 26.12.2023 and continue till 6.01.2024. The theory examinations will be conducted from 26.12.2023 to 03.01.2024, and practical examinations from 04.01.2024 to 06.01.2024. Detailed […]